MOLECULAR PARTNERS ADS/1 (6ML0) — Financial Flexibility Index
MOLECULAR PARTNERS ADS/1 (6ML0) has a Financial Flexibility Index of -0.51x as of December 2025. Free cash flow of €-11.01 Million (operating CF €-11.15 Million minus capex €139.00K) represents -1% of total liabilities (€21.77 Million). Also explore MOLECULAR PARTNERS ADS/1 (6ML0) equity growth momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
MOLECULAR PARTNERS ADS/1 Financial Flexibility Index (2021–2025)
Historical Financial Flexibility Index trend for MOLECULAR PARTNERS ADS/1 across 5 annual periods. Check MOLECULAR PARTNERS ADS/1 liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Annual Financial Flexibility Index for MOLECULAR PARTNERS ADS/1 (2021–2025)
Year-by-year free cash flow to debt coverage for MOLECULAR PARTNERS ADS/1. For the full company profile including market capitalisation, see MOLECULAR PARTNERS ADS/1 (6ML0) total market value.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -2.32x | €-50.54 Million | €-51.26 Million | €21.77 Million | ▲ +33.0% |
| 2024 | -3.46x | €-58.52 Million | €-59.25 Million | €16.89 Million | ▼ -30.5% |
| 2023 | -2.65x | €-58.20 Million | €-59.01 Million | €21.92 Million | ▼ -159.9% |
| 2022 | 4.43x | €119.98 Million | €118.57 Million | €27.09 Million | ▲ +423.0% |
| 2021 | -1.37x | €-89.65 Million | €-90.95 Million | €65.38 Million | — |